Back to results
US 2004/0005711 A1Published application
Genetic immunization against cervical carcinoma
AssigneeRijksuniversiteit Groningen
InventorsDjoeke Geesje Regts, Marijke Holtrop, Jan Christiaan Wilschut, Catharina Arnoldine H. H. Daemen
Life of this patent
Estimating the term…
Abstract
An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
Claims20
An alphavirus vector system comprising a nucleic acid molecule of human papilloma virus (HPV) origin.
Dependencies are inferred from the claim text.